Intrinsic Value of S&P & Nasdaq Contact Us

Liquidia Corporation LQDA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$50.67
+30.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Liquidia Corporation (LQDA) has a negative trailing P/E of -48.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 16.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -2.05%, forward earnings yield 6.23%. PEG 0.61 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (90/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.61); analyst target implies upside (+30.9%).
  • Forward P/E 16.1 — analysts expect a return to profitability with estimated EPS of $2.41 for FY2026.
  • PEG Ratio 0.61 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -2.05% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 6.23% as earnings recover.
  • Analyst consensus target $50.67 (+30.9% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 48/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
48/100
SG Score
View full scorecard →
VALUE
90/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
MOAT
70/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — LQDA

Valuation Multiples
P/E (TTM)-48.9
Forward P/E16.1
PEG Ratio0.61
Forward PEG0.61
P/B Ratio75.25
P/S Ratio21.52
EV/EBITDA-76.0
Per Share Data
EPS (TTM)$-0.79
Forward EPS (Est.)$2.41
Book Value / Share$0.51
Revenue / Share$1.82
FCF / Share$-0.46
Yields & Fair Value
Earnings Yield-2.05%
Forward Earnings Yield6.23%
Dividend Yield0.00%
Analyst Target$50.67 (+30.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -6.0 0.00 -5.22 7.21 -
2017 -3.3 -0.04 -2.83 13.13 -
2018 -2.9 -0.02 8.30 57.32 -
2019 -1.7 0.03 2.26 9.79 -
2020 -1.7 0.06 1.41 135.16 -
2021 -7.0 0.12 3.71 18.82 -
2022 -9.5 2.21 4.29 24.37 -
2023 -10.0 -0.12 16.53 44.71 -
2024 -7.1 -0.19 11.98 66.13 -
2025 -43.1 0.83 66.33 18.75 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-3.13 $13.22M $-15.93M -120.6%
2017 $-3.40 $7.26M $-29.15M -401.7%
2018 $-7.42 $2.71M $-53.14M -1962.9%
2019 $-2.51 $8.07M $-46.39M -574.7%
2020 $-1.70 $739.63K $-57.49M -7773%
2021 $-0.60 $12.85M $-29.78M -231.7%
2022 $-0.63 $15.94M $-38.37M -240.8%
2023 $-1.21 $17.49M $-78.5M -448.9%
2024 $-1.66 $14M $-130.39M -931.7%
2025 $-0.80 $158.32M $-68.92M -43.5%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $2.41 $0.25 – $3.80 $588.04M $519.72M – $662.18M 6
2027 $4.63 $0.43 – $6.35 $971.31M $658.75M – $1.22B 5
2028 $5.41 $0.44 – $8.94 $1.13B $1.13B – $1.13B 6
2029 $5.87 $3.36 – $8.10 $1.27B $852.75M – $1.64B 4
2030 $6.17 $3.54 – $8.52 $1.38B $924.23M – $1.78B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message